Production (Stage)
Raia Drogasil S.A.
RADLY
$2.47
-$0.17-6.44%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.10B | 7.22B | 7.30B | 7.28B | 7.13B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.10B | 7.22B | 7.30B | 7.28B | 7.13B |
| Cost of Revenue | 5.00B | 5.08B | 5.12B | 5.11B | 4.99B |
| Gross Profit | 2.10B | 2.15B | 2.18B | 2.17B | 2.14B |
| SG&A Expenses | 1.69B | 1.71B | 1.73B | 1.74B | 1.71B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.06M | 12.70M | -8.54M | -22.58M | -24.76M |
| Total Operating Expenses | 6.70B | 6.80B | 6.85B | 6.83B | 6.67B |
| Operating Income | 407.49M | 426.22M | 453.80M | 452.84M | 452.91M |
| Income Before Tax | 241.26M | 263.59M | 275.52M | 257.89M | 262.17M |
| Income Tax Expenses | 29.28M | 40.77M | 56.07M | 44.62M | 42.68M |
| Earnings from Continuing Operations | 211.98 | 222.82 | 219.45 | 213.27 | 219.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.30M | -2.22M | -5.72M | -5.89M | -6.49M |
| Net Income | 210.68M | 220.60M | 213.73M | 207.37M | 213.00M |
| EBIT | 407.49M | 426.22M | 453.80M | 452.84M | 452.91M |
| EBITDA | 536.47M | 557.56M | 587.42M | 588.22M | 587.87M |
| EPS Basic | 0.11 | 0.12 | 0.11 | 0.11 | 0.13 |
| Normalized Basic EPS | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 |
| EPS Diluted | 0.11 | 0.12 | 0.11 | 0.11 | 0.13 |
| Normalized Diluted EPS | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 |
| Average Basic Shares Outstanding | 7.81B | 7.82B | 7.88B | 7.92B | 6.73B |
| Average Diluted Shares Outstanding | 7.83B | 7.84B | 7.91B | 7.94B | 6.75B |
| Dividend Per Share | 0.02 | 0.02 | 0.07 | 0.04 | 0.05 |
| Payout Ratio | 40.88% | 39.05% | 44.02% | 45.30% | 44.20% |